Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Salicylic Acid

Base Information Edit
  • Chemical Name:Salicylic Acid
  • CAS No.:97952-82-4
  • Deprecated CAS:7681-06-3,8052-31-1,1186130-36-8,1186130-36-8,8052-31-1
  • Molecular Formula:C7H6O3
  • Molecular Weight:138.12074
  • Hs Code.:
  • European Community (EC) Number:200-712-3,308-377-6,305-634-4
  • ICSC Number:0563
  • NSC Number:180
  • UNII:O414PZ4LPZ
  • DSSTox Substance ID:DTXSID7026368
  • Nikkaji Number:J2.370A
  • Wikipedia:Salicylic acid
  • Wikidata:Q193572
  • NCI Thesaurus Code:C61934
  • RXCUI:9525
  • Pharos Ligand ID:FBKFP3SAJZML
  • Metabolomics Workbench ID:37916
  • ChEMBL ID:CHEMBL424
  • Mol file:97952-82-4.mol
Salicylic Acid

Synonyms:2 Hydroxybenzoic Acid;2-Hydroxybenzoic Acid;Acid, 2-Hydroxybenzoic;Acid, o-Hydroxybenzoic;Acid, ortho-Hydroxybenzoic;Acid, Salicylic;o Hydroxybenzoic Acid;o-Hydroxybenzoic Acid;ortho Hydroxybenzoic Acid;ortho-Hydroxybenzoic Acid;Salicylic Acid

Suppliers and Price of Salicylic Acid
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
Total 1 raw suppliers
Chemical Property of Salicylic Acid Edit
Chemical Property:
  • XLogP3:2.3
  • Hydrogen Bond Donor Count:2
  • Hydrogen Bond Acceptor Count:3
  • Rotatable Bond Count:1
  • Exact Mass:138.031694049
  • Heavy Atom Count:10
  • Complexity:133
Purity/Quality:

99% *data from raw suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Chemical Classes:Other Classes -> Benzoic Acid Derivatives
  • Canonical SMILES:C1=CC=C(C(=C1)C(=O)O)O
  • Recent ClinicalTrials:Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mild to Moderate Acne Vulgaris
  • Recent EU Clinical Trials:Effect of the administration of 75 mg of acetylsalicylic acid + 200mg of triglycerides of n-3 series fatty acids (omega 3 + ASA) on the biosynthesis of platelet thromboxane A2 in patients with cardiovascular disease.
  • Recent NIPH Clinical Trials:Effect of Guselkumab Treatment on Regulatory T-cell Subsets and Dendritic Cells Subsets in Psoriasis Patients
  • Inhalation Risk:Evaporation at 20 °C is negligible; a nuisance-causing concentration of airborne particles can, however, be reached quickly when dispersed.
  • Effects of Short Term Exposure:The substance is irritating to the eyes, skin and respiratory tract. The substance may cause effects on the central nervous system and acid-base balance in the body. This may result in delirium and tremors.
  • Effects of Long Term Exposure:Repeated or prolonged contact with skin may cause dermatitis.
Post RFQ for Price